Comparison of five point-of-care D-dimer assays with the standard laboratory method.

D-dimer (DD) assays are effective for the exclusion of deep-vein thrombosis (DVT), but point-of-care (POC) DD assays have not been fully evaluated.
We have compared five POC DD assays (Pathfast, Cardiac, Vidas, Stratus and NycoCard) with our routine DD method (Tinaquant), testing 60 samples from patients with suspected DVT.
Using 0.5 μg/mL as a cut-off value, four samples tested negative with Tinaquant were positive with Pathfast. There were no Tinaquant-positive samples tested negative with Pathfast, while the overall agreement (k = 0.81) was very good. Four samples were discrepant between Tinaquant and Cardiac (cut-off, 0.4 μg/mL), while k = 0.72. One of two Tinaquant-negative samples was shown to be positive for either Vidas (cut-off, 0.5 μg/mL) or Stratus (cut-off, 0.4 μg/mL), respectively. The agreement with Tinaquant was excellent for both Vidas (k = 0.92) and Stratus (k = 0.94). Total CV was <10% for all four assays. Eight samples (of 27) were negative with NycoCard although they were positive with Tinaquant, while CV was 41%.
Vidas cannot be considered a POC assay because the sample has to be centrifuged before testing. Our findings have also shown that the use of NycoCard is inappropriate. Stratus and Pathfast have a similar analytical profile in comparison with the Tinaquant method. Cardiac is potentially less sensitive but may still be acceptable for use. It seems that the employment of these three assays for rapid bed-side analysis offers a possibility to adequately rule out DVT in outpatients within minutes after admission.
AuthorsJ P Antovic, K Höög Hammarström, G Forslund, J Eintrei, M Sten-Linder
JournalInternational journal of laboratory hematology (Int J Lab Hematol) Vol. 34 Issue 5 Pg. 495-501 (Oct 2012) ISSN: 1751-553X [Electronic] England
PMID22487380 (Publication Type: Comparative Study, Journal Article)
Copyright© 2012 Blackwell Publishing Ltd.
Chemical References
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Clinical Laboratory Techniques (methods, standards)
  • Enzyme-Linked Immunosorbent Assay (methods, standards)
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Humans
  • Point-of-Care Systems (standards)
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Venous Thromboembolism (blood, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: